Microbot attending SIO conference; LIBERTY limited release ongoing, full release planned April 2026

Microbot Medical Inc.

Microbot Medical (MBOT) attending Society of Interventional Oncology conference Feb 4-8, 2026 in Savannah, GA.
Company will share physician experiences with LIBERTY Endovascular Robotic System from limited market release.
First commercial exhibition of LIBERTY since limited market release began in late 2025.
Full market release of LIBERTY planned for April 2026 at SIR conference.
LIBERTY is FDA-cleared, single-use, remotely operated robotic system for peripheral procedures.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-005206
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-02-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.909914+00:00
generated_at: 2026-05-16T04:43:42.208709+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-005206
json_url: https://secwatch.observer/filing/0001493152-26-005206.json
markdown_url: https://secwatch.observer/filing/0001493152-26-005206.md
text_url: https://secwatch.observer/filing/0001493152-26-005206.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226005206/0001493152-26-005206-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226005206/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-005206

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.